Vincent L Cryns

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Topics

Transcription Factor

Breast Cancer Cells

Top Venues

The EMBO journal

Breast cancer research and treatment

Nature cell biology

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Oisun Jung, Min-Jeong Baek, Colin Wooldrik, Keith R Johnson, Kurt W Fisher, Jinchao Lou, Tanei J Ricks, Tianmu Wen, Michael D Best, Vincent L Cryns, Richard A Anderson, Suyong Choi
Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer. The EMBO journal 43 (9) (2024)
Oisun Jung, Min-Jeong Baek, Colin Wooldrik, Keith R Johnson, Kurt W Fisher, Jinchao Lou, Tanei J Ricks, Tianmu Wen, Michael D Best, Vincent L Cryns, Richard A Anderson, Suyong Choi
Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer. The EMBO journal 43 (9) (2024)
Oisun Jung, Min-Jeong Baek, Colin Wooldrik, Keith R Johnson, Kurt W Fisher, Jinchao Lou, Tanei J Ricks, Tianmu Wen, Michael D Best, Vincent L Cryns, Richard A Anderson, Suyong Choi
Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer. The EMBO journal (2024)
Oisun Jung, Min-Jeong Baek, Colin Wooldrik, Keith R Johnson, Kurt W Fisher, Jinchao Lou, Tanei J Ricks, Tianmu Wen, Michael D Best, Vincent L Cryns, Richard A Anderson, Suyong Choi
Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer. The EMBO journal 43 (9) (2024)
Oisun Jung, Min-Jeong Baek, Colin Wooldrik, Keith R Johnson, Kurt W Fisher, Jinchao Lou, Tanei J Ricks, Tianmu Wen, Michael D Best, Vincent L Cryns, Richard A Anderson, Suyong Choi
Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer. The EMBO journal 43 (9) (2024)
Oisun Jung, Min-Jeong Baek, Colin Wooldrik, Keith R Johnson, Kurt W Fisher, Jinchao Lou, Tanei J Ricks, Tianmu Wen, Michael D Best, Vincent L Cryns, Richard A Anderson, Suyong Choi
Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer. The EMBO journal 43 (9) (2024)
Tianmu Wen, Mo Chen, Vincent L Cryns, Richard A Anderson
Regulation of the poly(A) Polymerase Star-PAP by a Nuclear Phosphoinositide Signalosome. bioRxiv : the preprint server for biology (2024)
Noah D Carrillo, Mo Chen, Vincent L Cryns, Richard A Anderson
Lipid transfer proteins initiate nuclear phosphoinositide signaling. bioRxiv : the preprint server for biology (2023)
Mo Chen, Suyong Choi, Tianmu Wen, Changliang Chen, Narendra Thapa, Jeong Hyo Lee, Vincent L Cryns, Richard A Anderson
A p53-phosphoinositide signalosome regulates nuclear AKT activation. Nature cell biology 24 (7) (2022)
Dmitry Malin, Yoonkyu Lee, Olga Chepikova, Elena Strekalova, Alexis Carlson, Vincent L Cryns
Methionine restriction exposes a targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase. Breast cancer research and treatment 190 (3) (2021)
Mo Chen, Tianmu Wen, Hudson T Horn, Vishwanatha K Chandrahas, Narendra Thapa, Suyong Choi, Vincent L Cryns, Richard A Anderson
The nuclear phosphoinositide response to stress. Cell cycle (Georgetown, Tex.) 19 (3) (2020)
Olga E Chepikova, Dmitry Malin, Elena Strekalova, Elena V Lukasheva, Andrey A Zamyatnin, Vincent L Cryns
Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells. Breast cancer research and treatment 183 (3) (2020)
Suyong Choi, Mo Chen, Vincent L Cryns, Richard A Anderson
A nuclear phosphoinositide kinase complex regulates p53. Nature cell biology 21 (4) (2019)
Elena Strekalova, Dmitry Malin, Erin M M Weisenhorn, Jason D Russell, Dominik Hoelper, Aayushi Jain, Joshua J Coon, Peter W Lewis, Vincent L Cryns
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells. Breast cancer research and treatment 175 (1) (2019)
Elena Strekalova, Dmitry Malin, Harisha Rajanala, Vincent L Cryns
Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression. Breast cancer research and treatment 163 (3) (2017)